Skip to main content
Publications
Bonthapally V, Ma E, Viviani S, Radford J, Brice P, von Tresckow B, Thomas E, Teasell J, Gnanasakthy A, Odom DM. Healthcare utilization in the AETHERA trial: phase 3 Study of brentuximab vedotin in patients at increased risk of residual hodgkin lymphoma post-ASCT. Poster presented at the 13th International Conference on Malignant Lymphoma (ICML); June 17, 2015. Lugano, Switzerland.
Bonthapally V, Ma E, Viviani S, Radford J, Brice P, von Tresckow B, Thomas E, Teasell J, Gnanasakthy A, Odom DM, Zhu Y, Lee S, Carlson P, Huebner D, Sweetenham J, Moskowitz C, Walewski J. Brentuximab vedotin in patients at increased risk of hodgkin lymphoma progression post autologous stem cell transplant: evaluation of healthcare resource utilization in the AETHERA trial. Poster presented at the 20th Congress of the European Hematology Association; June 2015. Vienna, Austria.
Williams V, Coles T, DeMuro C, Lewis S, Williams N, Yarr S, Barghout V, Lowes L, Alfano L, Goldberg B, Gnanasakthy A, Tseng B. Psychometric evaluation of the Sporadic Inclusion Body Myositis (sIBM) Physical Functioning Assessment (sIFA). Poster presented at the 1st Annual International Conference on Myositis; May 2015. Stockholm, Sweden.
Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FMJr, Tsiatis AA, Wilan AR, Mark DB, Schulman KA. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J. 2005 Mar;149(3):434-43.